For pharma

Poor adherence and lost follow-up is costly

  • Up to 50% of trial patients do not adhere to medications, costing pharma companies $637bn globally

  • Patients are less willing to share their data with pharma than mHealth

  • 3 in 5 patients use tech to monitor their health, which has more than tripled in the last 5 years but only 13% have experienced virtual care

  • UK healthcare consumers’ top desired uses of virtual care are:

  • Medication and health behaviour reminders

  • Daily support for ongoing health issues

  • Follow-up after in-person appointments or after hospitalisation

  • Discussion of specific health concerns with providers

  • After-hours appointments and examination of non-urgent conditions

Our solution

Enhanced patient experience and care

  • A customised application with multiple means of communication - messaging, questionnaires, video calling

  • Medications adherence, symptoms and vitals monitoring in real-time

  • Real-time patient reported outcomes feedback via our PROMs dashboard